About this formulation
Sermorelin acts on GHRH receptors in the pituitary gland, which take part in regulating the release of growth hormone. It was once the active ingredient of an FDA-approved medicine that is no longer marketed. We make no claim that it slows aging, builds muscle or changes body composition.
Ingredient overview
- SermorelinGrowth hormone-releasing hormone analogue
Important clinical considerations
No medical benefit is claimed for this preparation. Whether a Sermorelin preparation is appropriate for a patient, and in what form, is a decision for the prescriber based on that patient's clinical needs.
Prescription and eligibility
Available only with a valid prescription written by a licensed prescriber for an individual, identified patient. The pharmacist performs a medication review on every prescription and confirms the details with the prescriber. The prescriber is responsible for verifying that the patient has met all health requirements and is cleared to receive this compounded medication.
Safety disclosures
Compounded medications are not FDA-approved. The FDA has not evaluated this compounded preparation for safety, effectiveness or quality. It is prepared with active pharmaceutical ingredients from FDA-registered manufacturers, for an individual patient pursuant to a valid prescription. The FDA-approved sermorelin product it was part of is no longer marketed. Injectable preparations are compounded under USP General Chapter <797> for sterile preparations, and no preparation is released until third-party testing for potency, sterility, pH and endotoxins is complete with passing results. Each preparation comes with an informational brochure on storage and use.
Compounded medications are not FDA-approved. They are prepared with active pharmaceutical ingredients from FDA-registered manufacturers, for individual patients pursuant to a valid prescription from a licensed prescriber.